ESTRO35 Programme Book

ELECTRONIC POSTERS

> Primary (chemo)radiation therapy in organ-sparing treatment of tongue squamous cell carcinoma A. Gevorkov (Russian Federation), A. Boyko > Patient reported voice outcomes after laser surgery or radiotherapy for T1 laryngeal cancer R. Simcock (UK), D. Walker, A. Addison, M. Harries > Reirradiation results in head and neck tumours L. Gutierrez Bayard (Spain), M. Salas Buzón, L. De Ingunza Barón, S. Garduño Sánchez, E. González Calvo, I. Villanego Beltrán, V. Díaz Díaz, L. Díaz Gómez > Post-treatment FDG-PET CT in detecting residual disease in head & neck squamous cell carcinoma J. Price (UK), A. Pascoe, C. Weston, S. Kathirgamakarthigeyan, M. Griffin, R. Ganatra, J. Christian > Low FDG-PET detection rate of the primary tumor for patients with cervical lymph node metastases E. Dale (Norway), J.M. Moan, T.V. Bogsrud > Assessing the outcome in 3D and IMRT head and neck (H&N) cancer patients: are we doing well? I. Prieto (Spain), J. Luna, J. Olivera, J. Vara, A. Perez > Impact of pretreatment primary tumor volume on survival of patient with T4a larynx cancer A. Mohamed, J. Shiao (USA), J. Messer, W. Morrison, M. Zafereo, A. Hessel, S. Lai, M. Kies, R. Ferrarotto, A. Garden, R. Weber, D. Rosenthal, C.D. Fuller > Nasopharyngeal carcinoma screening by plasma EBV DNA and serum antibodies in an outpatient clinic C.W. Twu (Taiwan), J. Jin-Ching Lin, W. Wen-Yi Wang > Prognostic role of FDG-PET performed before or during radiotherapy in head and neck cancer M. Min (Australia), P. Lin, M. Lee, I. Ho Shon, M. Lin, D. Forstner, M.T. Tieu, A. Chicco, V. Bray, A. Fowler > Maintenance metronomic chemotherapy for recurrent/metastatic nasopharyngeal carcinoma C. Wu (Taiwan), W.Y. Wang, C.W. Twu, P.J. Lin, Y.C. Liu, J.C. Lin

EP-1062

EP-1063

EP-1064

EP-1065

EP-1066

EP-1067

EP-1068

EP-1069

EP-1070

EP-1071

POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE

215